These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
77 related articles for article (PubMed ID: 32069066)
41. [Indications for the use of continuous subcutaneous insulin infusion in pediatric patients with type 1 diabetes mellitus]. Espejel-Huerta D; Antillón-Ferreira CA; Iglesias-Leboreiro J; Bernárdez-Zapata I; Martínez-Ramos Méndez A; Rendón-Macías ME Rev Med Inst Mex Seguro Soc; 2016; 54(1):64-9. PubMed ID: 26820201 [TBL] [Abstract][Full Text] [Related]
42. An online failure detection method of the glucose sensor-insulin pump system: improved overnight safety of type-1 diabetic subjects. Facchinetti A; Del Favero S; Sparacino G; Cobelli C IEEE Trans Biomed Eng; 2013 Feb; 60(2):406-16. PubMed ID: 23193300 [TBL] [Abstract][Full Text] [Related]
43. Classification of distinct baseline insulin infusion patterns in children and adolescents with type 1 diabetes on continuous subcutaneous insulin infusion therapy. Holterhus PM; Odendahl R; Oesingmann S; Lepler R; Wagner V; Hiort O; Holl R; ; Diabetes Care; 2007 Mar; 30(3):568-73. PubMed ID: 17327322 [TBL] [Abstract][Full Text] [Related]
44. The cost-effectiveness of continuous subcutaneous insulin infusion compared with multiple daily injections for the management of diabetes. Scuffham P; Carr L Diabet Med; 2003 Jul; 20(7):586-93. PubMed ID: 12823242 [TBL] [Abstract][Full Text] [Related]
45. Using technology to advance type 1 diabetes care among women during the reproductive years and in pregnancy. Polsky S; Giordano D; Voelmle MK; Garcetti R; Garg SK Postgrad Med; 2016 May; 128(4):418-26. PubMed ID: 26924774 [TBL] [Abstract][Full Text] [Related]
46. Continuous subcutaneous insulin infusion (CSII) versus multiple daily injections (MDI) of rapid-acting insulin analogues and detemir in type 1 diabetic (T1D) pregnant women. Mello G; Biagioni S; Ottanelli S; Nardini C; Tredici Z; Serena C; Marchi L; Mecacci F J Matern Fetal Neonatal Med; 2015 Feb; 28(3):276-80. PubMed ID: 24724804 [TBL] [Abstract][Full Text] [Related]
47. Continuous subcutaneous insulin infusion (CSII) 30 years later: still the best option for insulin therapy. Bruttomesso D; Costa S; Baritussio A Diabetes Metab Res Rev; 2009 Feb; 25(2):99-111. PubMed ID: 19172576 [TBL] [Abstract][Full Text] [Related]
48. Usability and training differences between two personal insulin pumps. Schaeffer NE; Parks LJ; Verhoef ET; Bailey TS; Schorr AB; Davis T; Halford J; Sulik B J Diabetes Sci Technol; 2015 Mar; 9(2):221-30. PubMed ID: 25316715 [TBL] [Abstract][Full Text] [Related]
49. Insulin induces a progressive increase in the resistance of subcutaneous tissue to fluid flow: Implications for insulin pump therapy. Regittnig W; Tschaikner M; Tuca AC; Simic A; Feiel J; Schaller-Ammann R; Licht AH; Jungklaus M; Pieber TR Diabetes Obes Metab; 2022 Mar; 24(3):455-464. PubMed ID: 34739179 [TBL] [Abstract][Full Text] [Related]
51. Analysis of novel methods to determine the accuracy of the OmniPod insulin pump: a key component of the artificial pancreas system. Ochoa M; Ziaie B J Diabetes Sci Technol; 2011 Nov; 5(6):1519-20. PubMed ID: 22226274 [TBL] [Abstract][Full Text] [Related]
52. Insulin pump (dose-to-dose) accuracy: what does it mean and when is it important? Zisser H J Diabetes Sci Technol; 2014 Nov; 8(6):1142-4. PubMed ID: 25165076 [TBL] [Abstract][Full Text] [Related]
54. Accuracy of a Low-Cost Continuous Subcutaneous Insulin Infusion Pump Prototype: In Vitro Study Using Combined Methodologies. Tenorio FS; Martins LEG; Cunha TS Ann Biomed Eng; 2021 Jul; 49(7):1761-1773. PubMed ID: 33495976 [TBL] [Abstract][Full Text] [Related]
55. Description of a Novel Patch Pump for Insulin Delivery and Comparative Accuracy Evaluation. Baumstark A; Mende J; Uchiyama J; Haug C; Freckmann G J Diabetes Sci Technol; 2022 Jul; 16(4):971-975. PubMed ID: 33736474 [TBL] [Abstract][Full Text] [Related]
56. Analysis of the environmental impact of insulin infusion sets based on loss of resources with waste. Pfützner A; Musholt PB; Malmgren-Hansen B; Nilsson NH; Forst T J Diabetes Sci Technol; 2011 Jul; 5(4):843-7. PubMed ID: 21880223 [TBL] [Abstract][Full Text] [Related]
57. Detailed Analysis of Insulin Absorption Variability and the Tissue Response to Continuous Subcutaneous Insulin Infusion Catheter Implantation in Swine. Hauzenberger JR; Hipszer BR; Loeum C; McCue PA; DeStefano M; Torjman MC; Kaner MT; Dinesen AR; Chervoneva I; Pieber TR; Joseph JI Diabetes Technol Ther; 2017 Nov; 19(11):641-650. PubMed ID: 28981324 [TBL] [Abstract][Full Text] [Related]
58. The OmniPod Insulin Management System: the latest innovation in insulin pump therapy. Zisser HC Diabetes Ther; 2010 Aug; 1(1):10-24. PubMed ID: 22127670 [TBL] [Abstract][Full Text] [Related]
59. The Relationship Between Different Bench Test Methodologies and Accuracy of Insulin Infusion Pumps: A Systematic Literature Review. Tenorio FS; Martins LEG; da Silva GSP; Martins CB; Neves ALD; Cunha TS Ann Biomed Eng; 2022 Oct; 50(10):1255-1270. PubMed ID: 35953739 [TBL] [Abstract][Full Text] [Related]
60. Calibration of insulin pumps based on discrete doses at given cycle times. Bissig H; Büker O; Stolt K; Batista E; Afonso J; Zagnoni M; Vroman R; Kjeldsen H; Niemann A; Schroeter J Biomed Tech (Berl); 2023 Feb; 68(1):67-77. PubMed ID: 36165737 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]